Search

Author/Creator Cohn, Susan L

1. Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma. Issue 7 (16th July 2021)

Authors:
Bao, Riyue; Spranger, Stefani; Hernandez, Kyle; Zha, Yuanyuan; Pytel, Peter; Luke, Jason J; Gajewski, Thomas F; Volchenboum, Samuel L; Cohn, Susan L; Desai, Ami V
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 7(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial. (January 2018)

Authors:
de Alarcon, Pedro A; Matthay, Katherine K; London, Wendy B; Naranjo, Arlene; Tenney, Sheena C; Panzer, Jessica A; Hogarty, Michael D; Park, Julie R; Maris, John M; Cohn, Susan L
Journal:
Lancet
Issue:
Volume 2:Number 1(2018)
Page Start:
25
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial. Issue 1 (January 2020)

Authors:
Geoerger, Birgit; Kang, Hyoung Jin; Yalon-Oren, Michal; Marshall, Lynley V; Vezina, Catherine; Pappo, Alberto; Laetsch, Theodore W; Petrilli, Antonio S; Ebinger, Martin; Toporski, Jacek; Glade-Bender, Julia; Nicholls, Wayne; Fox, Elizabeth; DuBois, Steven G; Macy, Margaret E; Cohn, Susan L; Pathi...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 1(2020)
Page Start:
121
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗